Aging Mind Foundation

Tauopathy Challenge Workshop Winner, Kathryn Bowles, research focuses on understanding how build-up of tau affects astrocytes, one of the main cell types in the brain, and the role of astrocytes in the development and progression of PSP. Specifically, Dr. Bowles will investigate how astrocytes behave when they have a build-up of tau, and subsequently, how aggregated tau in astrocytes contributes to making neurons sick. This has not been previously studied. Read more about Kathryn's research: https://bit.ly/4eUDti0

Scientists have identified the brain's waste-clearing system in living humans, shedding light on how it removes harmful buildup, like proteins linked to Alzheimer’s. Using advanced imaging, researchers confirmed the glymphatic system, active during sleep, flushes out waste through channels around blood vessels. This discovery offers new insights into brain health and the link between sleep and dementia. Source: ABC News

An unforgettable night filled with incredible food, great company, and shared passion for a cause that’s close to our hearts. Thank you to our generous hosts, Monica and Joe Eastin, for opening your beautiful home and to Chef Bobby from AT Bistro Dallas, Ashley from 55seventy, and Deanna Wheeler for creating such a special evening. Your support makes a difference in our mission to fund groundbreaking Alzheimer's research. Here's to more memorable moments! 🧠 🌟 💛

One of our Tauopathy Challenge Workshop awardees, Dr. Patrik Verstreken, was selected for his research that is advancing our potential to target synaptic tau abilities by studying hibernating animals, specifically hamsters. His approach aims to identify new targets that may counteract synapse loss for patients living with tau-related neurodegenerative diseases. Learn more about Dr. Verstreken’s research: https://bit.ly/4cDBj4E

Tauopathy Challenge Workshop winners Dr. Yongku Cho and Dr. Jesse Rinehart are leveraging cutting-edge technology in pursuit of discovering better solutions for people living with neurodegenerative diseases. Their work recreates neuron cells in the lab through a modern science approach to study the modifications of the cells impacted by tau proteins to search for patterns. See Drs. Cho and Rinehart’s technological approach to studying primary tauopathies: https://lnkd.in/eXgt8-pq

Did you know? A recent study published by CNN revealed that swapping a small daily serving of processed red meat for nuts and legumes can reduce your risk of dementia by 20% The study also found that consuming 1 ounce of processed red meat daily can increase the risk of dementia by 14%. Make smart choices for a healthier mind!🧠 🌟

Nearly half of the 1.28 billion adults with high blood pressure globally don’t even know they have it, says the World Health Organization A new study shows that untreated hypertension can increase the risk of Alzheimer’s by 36% and raise the risk of other dementias by up to 69%. The good news? Treating high blood pressure can significantly reduce these risks, even for those in their 70s and 80s. But with only 1 in 5 adults keeping their blood pressure under control, it’s a reminder to stay on top of your health.

The FDA has approved Crexont, a new extended-release oral medication developed by Amneal Pharmaceuticals, designed to improve symptom control with fewer doses. This breakthrough promises more "on" time and a better quality of life for Parkinson's patients. Source: https://bit.ly/3YZ6Qef.

We are excited that our collaboration with The Rainwater Charitable Foundation and CurePSP was featured in Outsourcing-Pharma. Read the full article below to learn more about the progress being made in uncovering the causes of Alzheimer's Disease and other dementias. Read the full article here https://bit.ly/4dawcu8

Thanks to the Women's Alzheimer's Movement for sharing this insightful discussion! 🧠 Dr. Jagan Pillai breaks down the new FDA-approved anti-amyloid drug, Donanemab. Learn about this exciting development in Alzheimer’s treatment and how it compares to other options.